Literature DB >> 26216471

Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane.

El-Sayed Khafagy1,2, Ruisha Iwamae1, Noriyasu Kamei1, Mariko Takeda-Morishita3.   

Abstract

We have reported that the cell-penetrating peptide (CPP) penetratin acts as a potential absorption enhancer in oral insulin delivery systems and that this action occurs through noncovalent intermolecular interactions. However, the region-dependent role of CPPs in intestinal insulin absorption has not been clarified. To identify the intestinal region where CPPs have the most effect in increasing insulin absorption, the region-dependent action of penetratin was investigated using in situ closed intestinal loops in rats. The order of the insulin area under the insulin concentration-time curve (AUC) increase effect by L-penetratin was ileum > jejunum > duodenum > colon. By contrast, the AUC order after coadministration of insulin with D-penetratin was colon > duodenum ≥ jejunum and ileum. We also compared the effects of the L- and D-forms of penetratin, R8, and PenetraMax on ileal insulin absorption. Along with the CPPs used in this study, L- and D-PenetraMax produced the largest insulin AUCs. An absorption study using ilea pretreated with CPPs showed that PenetraMax had no irreversible effect on the intestinal epithelial membrane. The degradation of insulin in the presence of CPPs was assessed in rat intestinal enzymatic fluid. The half-life (t 1/2) of insulin increased from 14.5 to 23.7 and 184.7 min in the presence of L- and D-PenetraMax, respectively. These enzymatic degradation-resistant effects might contribute partly to the increased ileal absorption of insulin induced by D-PenetraMax. In conclusion, this study demonstrated that the ability of the L- and D-forms of penetratin to increase intestinal insulin absorption was maximal in the ileum and the colon, respectively, and that D-PenetraMax is a powerful but transient enhancer of oral insulin absorption.

Entities:  

Keywords:  absorption enhancement; cell-penetrating peptide; enzymatic degradation; insulin; intestinal membrane

Mesh:

Substances:

Year:  2015        PMID: 26216471      PMCID: PMC4627450          DOI: 10.1208/s12248-015-9804-y

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  54 in total

1.  Diffusion coefficient in native mucus gel of rat small intestine.

Authors:  D Winne; W Verheyen
Journal:  J Pharm Pharmacol       Date:  1990-07       Impact factor: 3.765

2.  Regional small-intestinal permeability in vitro to different-sized dextrans and proteins in the rat.

Authors:  N Pantzar; B R Weström; A Luts; S Lundin
Journal:  Scand J Gastroenterol       Date:  1993-03       Impact factor: 2.423

3.  In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.

Authors:  Ebbe Juel Bech Nielsen; Shinya Yoshida; Noriyasu Kamei; Ruisha Iwamae; El-Sayed Khafagy; Jørgen Olsen; Ulrik Lytt Rahbek; Betty Lomstein Pedersen; Kozo Takayama; Mariko Takeda-Morishita
Journal:  J Control Release       Date:  2014-06-25       Impact factor: 9.776

4.  Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.

Authors:  Yu-Hsin Lin; Kiran Sonaje; Kurt M Lin; Jyuhn-Huarng Juang; Fwu-Long Mi; Han-Wen Yang; Hsing-Wen Sung
Journal:  J Control Release       Date:  2008-09-09       Impact factor: 9.776

5.  Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin.

Authors:  M Morishita; I Morishita; K Takayama; Y Machida; T Nagai
Journal:  Biol Pharm Bull       Date:  1993-01       Impact factor: 2.233

6.  Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.

Authors:  Noriyasu Kamei; Mariko Morishita; Jumpei Ehara; Kozo Takayama
Journal:  J Control Release       Date:  2008-07-18       Impact factor: 9.776

7.  Intestinal absorption and excretion of octapeptides composed of D amino acids.

Authors:  J R Pappenheimer; C E Dahl; M L Karnovsky; J E Maggio
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

8.  The role of intermolecular interactions with penetratin and its analogue on the enhancement of absorption of nasal therapeutic peptides.

Authors:  El-Sayed Khafagy; Mariko Morishita; Kozo Takayama
Journal:  Int J Pharm       Date:  2010-01-08       Impact factor: 5.875

Review 9.  Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans.

Authors:  André Ziegler
Journal:  Adv Drug Deliv Rev       Date:  2007-10-22       Impact factor: 15.470

10.  Usefulness of cell-penetrating peptides to improve intestinal insulin absorption.

Authors:  Noriyasu Kamei; Mariko Morishita; Yoshimi Eda; Nobuo Ida; Reiji Nishio; Kozo Takayama
Journal:  J Control Release       Date:  2008-08-06       Impact factor: 9.776

View more
  2 in total

1.  Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.

Authors:  Bader B Alsulays; Md Khalid Anwer; Gamal A Soliman; Sultan M Alshehri; El-Sayed Khafagy
Journal:  Int J Nanomedicine       Date:  2019-11-25

2.  α-synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease.

Authors:  Brian Spencer; Stephanie Williams; Edward Rockenstein; Elvira Valera; Wei Xin; Michael Mante; Jazmin Florio; Anthony Adame; Eliezer Masliah; Michael R Sierks
Journal:  Ann Clin Transl Neurol       Date:  2016-06-16       Impact factor: 4.511

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.